Efficacy and safety of atorvastatin in hyperlipidemic, type 2 diabetic patients. A 34-week, multicenter, open-label study
Carlos A. Aguilar-Salinas, Francisco J. Gómez-Pérez, Carlos Posadas-Romero, Cuauhtémoc Vázquez-Chávez, Eduardo Meaney, Alfonso Gulı́as-Herrero, Luz E. Guillén, Alma Alvarado Vega, Enrique Mendoza PéreТом:
152
Рік:
2000
Мова:
english
DOI:
10.1016/s0021-9150(99)00502-x
Файл:
PDF, 156 KB
english, 2000